Exploratory Clinical Study of Anti-CD19/BCMA Universal CAR-T Cell Injection for the Treatment of Refractory Autoimmune Diseases

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2026
A single arm, open-label pilot study is designed to determine the safety and effectiveness of anti-CD19/BCMA-UCAR-T cells in patients with autoimmune diseases. 36-72 patients are planned to be enrolled in the dose-escalation trial.
Epistemonikos ID: 6880f453930ed62a14f8577fc85ef9a3d1b9c1d4
First added on: May 01, 2026